---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-104054"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2025-08-06T23:59:59+00:00"
generated_at: "2026-05-17T19:10:32.184896+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Outset Medical Q2 revenue up 15% to $31.4M; raises FY2025 guidance to $122-126M

## Summary
- Net revenue $31.4M (+15% YoY); Tablo console revenue up 25%; recurring revenue $22.5M (+11%).
- Non-GAAP gross margin 38.4% (+110bps); operating expenses down 29% YoY; net loss $18.5M vs $34.5M.
- Raised 2025 revenue guidance to $122-126M from $115-125M; expects <$50M cash use vs >$100M in 2024.
- New enterprise agreement with large national health system; Tablo now in >900 U.S. acute/sub-acute sites.
- Cash $187.4M at June 30; H1 cash burn reduced ~60% vs prior year.

## SEC filing metadata
- accession: 0000950170-25-104054
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2025-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000095017025104054/0000950170-25-104054-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000095017025104054/om-20250806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-104054
- JSON: https://secwatch.observer/filing/0000950170-25-104054.json
- Plain text: https://secwatch.observer/filing/0000950170-25-104054.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.